Metabolite

KNApSAcK Entry

id C00019660
Name Xanthine
CAS RN 69-89-6
Standard InChI InChI=1S/C5H4N4O2/c10-4-2-3(7-1-6-2)8-5(11)9-4/h1H,(H3,6,7,8,9,10,11)
Standard InChI (Main Layer) InChI=1S/C5H4N4O2/c10-4-2-3(7-1-6-2)8-5(11)9-4/h1H,(H3,6,7,8,9,10,11)

Cluster

Phytochemical cluster No. 12
KCF-S cluster No. 2266

Link

ChEMBL

By standard InChI CHEMBL1424
By standard InChI Main Layer CHEMBL1424

KEGG

By LinkDB C00385

CTD

By CAS RN D019820

Species

Summary

Plant class

class name count

Family

family name count
Enterobacteriaceae 1

List (1)

* NCBI
KNApSAcK organism *ID *family *plant class *kingdom
Escherichia coli K12 83333 Enterobacteriaceae Bacteria

Human Protein / Gene in interaction

8 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
P00492 Hypoxanthine-guanine phosphoribosyltransferase Enzyme CHEMBL1424 CHEMBL909307 (1) CHEMBL853907 (1)
2 / 1
Q9Y2T3 Guanine deaminase Enzyme CHEMBL1424 CHEMBL1225632 (1) CHEMBL1225633 (1)
0 / 0
P10828 Thyroid hormone receptor beta NR1A2 CHEMBL1424 CHEMBL1794561 (1)
3 / 1
P29274 Adenosine receptor A2a Adenosine receptor CHEMBL1424 CHEMBL680424 (1)
0 / 0
Q08493 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE_4C CHEMBL1424 CHEMBL821509 (1)
0 / 0
Q07343 cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE_4B CHEMBL1424 CHEMBL821509 (1)
0 / 0
P27815 cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE_4A CHEMBL1424 CHEMBL821509 (1)
0 / 0
Q08499 cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE_4D CHEMBL1424 CHEMBL821509 (1)
1 / 0

CTD interaction (7)

compound gene gene name gene description interaction interaction type form reference
pmid
D019820 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) [Xanthine co-treated with XDH protein] results in increased activity of CASP3 protein affects cotreatment
/ increases activity
protein 19268487
D019820 847 CAT
catalase (EC:1.11.1.6) CAT protein inhibits the reaction [[[Xanthine co-treated with XDH protein] results in increased abundance of Superoxides] which results in increased secretion of TGFB1 protein] affects cotreatment
/ decreases reaction
/ increases abundance
/ increases secretion
protein 19268487
D019820 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 CAT protein inhibits the reaction [[[Xanthine co-treated with XDH protein] results in increased abundance of Superoxides] which results in increased secretion of TGFB1 protein] affects cotreatment
/ decreases reaction
/ increases abundance
/ increases secretion
protein 19268487
D019820 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 [[Xanthine co-treated with XDH protein] results in increased abundance of Superoxides] which results in increased secretion of TGFB1 protein affects cotreatment
/ increases abundance
/ increases secretion
protein 19268487
D019820 7498 XDH
XO
XOR
xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) CAT protein inhibits the reaction [[[Xanthine co-treated with XDH protein] results in increased abundance of Superoxides] which results in increased secretion of TGFB1 protein] affects cotreatment
/ decreases reaction
/ increases abundance
/ increases secretion
protein 19268487
D019820 7498 XDH
XO
XOR
xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) [[Xanthine co-treated with XDH protein] results in increased abundance of Superoxides] which results in increased secretion of TGFB1 protein affects cotreatment
/ increases abundance
/ increases secretion
protein 19268487
D019820 7498 XDH
XO
XOR
xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) [Xanthine co-treated with XDH protein] results in increased activity of CASP3 protein affects cotreatment
/ increases activity
protein 19268487

Related Disease

Diseases related to proteins in ChEMBL interactions

OMIM (6)

OMIM preferred title UniProt
#614613 Acrodysostosis 2, with or without hormone resistance; acrdys2 Q08499
#300323 Kelley-seegmiller syndrome P00492
#300322 Lesch-nyhan syndrome; lns P00492
#188570 Thyroid hormone resistance, generalized, autosomal dominant; grth P10828
#274300 Thyroid hormone resistance, generalized, autosomal recessive; grth P10828
#145650 Thyroid hormone resistance, selective pituitary; prth P10828

KEGG DISEASE (2)

KEGG disease name UniProt
H00194 Lesch-Nyhan syndrome P00492 (related)
H00249 Thyroid hormone resistance syndrome P10828 (related)

Diseases related to CTD interactions

2 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D019970 D019820 Cocaine-Related Disorders marker/mechanism
19649617
D009410 D019820 Nerve Degeneration marker/mechanism
9147382